PERSONALIZED CELL THERAPY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Personalized Cell Therapy Market, By Cell Type (Lymphocytes, Mesenchymal Stem Cell, Hematopoietic Stem Cell Others), By Therapeutic Area (Cardiovascular Diseases, Neurological Disorders, Inflammatory Diseases, Diabetes, Cancer), By End Users (Hospitals, Homecare, Specialty Clinics, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In: 03 Apr, 2026
Code: CMI204
Page number: 157
Formats: Excel and PDF
Industry: Biotechnology
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Cell Type
  - Market Snapshot, By Therapeutic Area
  - Market Snapshot, By End User
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter’s Analysis
Global Personalized Cell Therapy Market, By Cell Type, 2021 – 2033, (USD Bn)
- Overview
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2021 – 2033
  - Segment Trends
- Lymphocytes
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Mesenchymal Stem Cell
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Hematopoietic Stem Cell
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
Global Personalized Cell Therapy Market, By Therapeutic Area, 2021 – 2033, (USD Bn)
- Overview
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2021 – 2033
  - Segment Trends
- Cardiovascular Diseases
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Neurological Disorders
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Inflammatory Diseases
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Diabetes
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Cancer
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
Global Personalized Cell Therapy Market, By End Users, 2021 – 2033, (USD Bn)
- Overview
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2021 – 2033
  - Segment Trends
- Hospitals
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Homecare
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Specialty Clinics
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
Global Personalized Cell Therapy Market, By Region, 2021 – 2033, (USD Bn)
- Introduction
  - Market Share Analysis, By Region, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Region, 2021–2033
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Thermo Fisher Scientific, Inc.
    - Company Highlights
    - Therapeutic Area Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Novartis AG
    - Company Highlights
    - Therapeutic Area Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Gilead Sciences, Inc.
    - Company Highlights
    - Therapeutic Area Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Pfizer Inc.
    - Company Highlights
    - Therapeutic Area Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Amgen Inc.
    - Company Highlights
    - Therapeutic Area Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Bluebird Bio, Inc.
    - Company Highlights
    - Therapeutic Area Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Personalis, Inc.
    - Company Highlights
    - Therapeutic Area Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Adaptimmune Therapeutics PLC
    - Company Highlights
    - Therapeutic Area Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - BioNTech SE
    - Company Highlights
    - Therapeutic Area Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Sangamo Therapeutics, Inc.
    - Company Highlights
    - Therapeutic Area Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Regeneron Pharmaceuticals, Inc.
    - Company Highlights
    - Therapeutic Area Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - CRISPR Therapeutics AG
    - Company Highlights
    - Therapeutic Area Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Caribou Biosciences, Inc.
    - Company Highlights
    - Therapeutic Area Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Mustang Bio, Inc.
    - Company Highlights
    - Therapeutic Area Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Fate Therapeutics, Inc.
    - Company Highlights
    - Therapeutic Area Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Atara Biotherapeutics, Inc.
    - Company Highlights
    - Therapeutic Area Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Holostem Terapie Avanzate S.r.l
    - Company Highlights
    - Therapeutic Area Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact

*Browse 32 market data tables and 28 figures on "Personalized Cell Therapy Market” - Global forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now